Krishna Institute of Medical Sciences (KIMS Hospitals), a leading healthcare provider in India, has reported robust growth in its first quarter of fiscal year 2026, while simultaneously pursuing ambitious expansion plans across multiple cities.

Financial Performance

KIMS Hospitals demonstrated strong financial performance in Q1 FY26:

• Total revenue reached ₹879.00 crore, marking a significant year-on-year growth of 26.80% and a quarter-on-quarter increase of 9.60%.
• EBITDA stood at ₹200.00 crore, showing an 8.50% year-on-year growth.
• The company's EBITDA margin was 22.70% for Q1 FY26.
• Profit After Tax (PAT) was reported at ₹85.00 crore.

Operational Highlights

The company also showed impressive operational metrics:

• Inpatient (IP) volume increased by 15.30% year-on-year to 57,275.
• Outpatient (OP) volume grew by 19.30% year-on-year to 5,02,492.
• Average Revenue Per Operating Bed (ARPOB) rose by 11.80% year-on-year to ₹43,011.
• Average Revenue Per Patient (ARPP) increased by 9.80% year-on-year to ₹1,53,094.

Expansion Initiatives

KIMS Hospitals is actively pursuing growth through several expansion projects:

Bengaluru

• Two new projects are underway, with 450 beds and 350 beds respectively, offering comprehensive specialties.
• These projects are expected to be operational by Q2 FY26.

Ongole

• Adding 50 beds and a Cancer Centre to the existing 350-bed facility.
• Expected investment of ₹40.00-50.00 crore.

Anantapur

• Expanding the current 250-bed hospital with an additional 250 beds.
• Introducing a Cancer Centre and Mother & Child care facilities.
• Project estimated at ₹90.00-110.00 crore, slated for completion by Q4 FY26.

Kondapur

• Significant expansion of 500 beds to the existing 200-bed facility.
• Projected investment of ₹300.00-350.00 crore.
• Expected completion by Q1 FY27.

Rajahmundry

• Establishing a new 350-bed multispecialty hospital.
• Investment of ₹300.00-350.00 crore.
• Set to be operational by Q4 FY27.

New Facility in Thane

KIMS Hospitals has recently opened a new 300+ bedded multispecialty hospital in Thane, Maharashtra. The facility boasts state-of-the-art medical technology, including:

• 10 operating theaters
• 70+ ICU beds
• 2 Cath Labs
• Advanced imaging equipment

Dr. B Bhaskar Rao, CMD of KIMS Hospitals, commented on the Q1 performance: "First quarter of FY 26 has started on a robust note with all engines performing optimally. Despite being a seasonally lean quarter, we have managed to grow on key parameters. Patient footfalls have seen a good uptick in all units especially in new ones like Thane. I am optimistic that we are on track to meet our targets for FY 26. Our 2 units of Bangalore will be commencing in Q2."

With its strong financial performance and aggressive expansion plans, KIMS Hospitals is positioning itself for continued growth in the Indian healthcare sector, focusing on providing affordable, quality care across multiple regions.

Krishna Institute of Medical Sciences (KIMS Hospitals) has announced its financial results for the first quarter, reporting strong revenue growth but a decline in profitability.

Financial Highlights

• Total revenue reached ₹879.00 crores, representing a 26.8% year-on-year growth and 9.6% quarter-on-quarter growth.
• EBITDA stood at ₹200.00 crores, showing 8.5% YoY growth but a 1.4% QoQ decline.
• EBITDA margin compressed to 22.7% from 26.6% in the same quarter of the previous year and 25.3% in the preceding quarter.
• Profit after tax decreased to ₹85.00 crores from ₹95.00 crores in the same quarter of the previous year and ₹106.00 crores in the preceding quarter.
• Consolidated earnings per share stood at ₹1.96, down 9.2% YoY.

Operational Performance

KIMS Hospitals reported strong operational metrics:

• Inpatient volume grew 15.3% YoY to 57,275.
• Outpatient volume increased 19.3% YoY to 5,02,492.
• Average revenue per occupied bed (ARPOB) rose 11.8% YoY to ₹43,011.00.

Financial Position

The company reported cash and equivalents totaling ₹70.00 crores.

Management Commentary

Dr. B Bhaskar Rao, CMD of KIMS Hospitals, noted robust performance despite the seasonally lean quarter and confirmed that two Bangalore units will commence operations in the next quarter.

Board Meeting and Result Approval

The Board of Directors of Krishna Institute of Medical Sciences convened on August 6 to review and approve the financial results. The meeting, which began at 1:30 PM and concluded at 2:30 PM, saw the approval of unaudited standalone and consolidated financial results for the quarter ended June 30.

Transparency and Compliance

In line with regulatory requirements, KIMS has made its financial results available on the company's official website ( https://www.kimshospitals.com/investors/Disclosures ) under the Financial Information section. The results are also accessible on the websites of BSE Ltd ( www.bseindia.com ) and the National Stock Exchange of India Ltd ( www.nseindia.com ).

Upcoming Investor Meeting

KIMS has informed stakeholders about an upcoming Analyst/Institutional Investor Meeting. The company is scheduled to participate in the Emkay Confluence, a group meeting to be held in Mumbai on August 12. This event provides an opportunity for analysts and institutional investors to gain insights into the company's performance and future outlook.

Conclusion

While Krishna Institute of Medical Sciences has experienced strong revenue growth, the company faces challenges in maintaining profitability. The expansion plans with new units in Bangalore and continued focus on operational metrics demonstrate KIMS Hospitals' commitment to growth and improved healthcare delivery. Stakeholders will be closely monitoring the company's performance in the coming quarters as it navigates the competitive healthcare landscape.